Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The circumsporozoite protein (CSP) is the most abundant surface protein on Plasmodium vivax sporozoites, the infectious form of the malaria parasite transmitted by mosquitoes. CSP is essential for parasite development, migration within the mosquito vector, and invasion of human hepatocytes during infection. It is a major target for neutralizing antibodies and a key vaccine candidate. Significant heterogeneity in its central repeat sequences among different isolates poses challenges for universal vaccine efficacy.
Antibodies targeting CSP neutralize sporozoites and prevent liver cell invasion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Circumsporozoite Protein (Plasmodium vivax) (PvCSP).